• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Johnson & Johnson MedTech uses Truveta Data to show Impella advantages over IABP

Johnson & Johnson MedTech uses Truveta Data to show Impella advantages over IABP

by Truveta staff | Nov 18, 2025 | Research

At the Transcatheter Cardiovascular Therapeutics (TCT) conference in October 2025, Johnson & Johnson MedTech presented two large, contemporary analyses that used Truveta Data to compare Impella microaxial heart pumps with intra-aortic balloon pump (IABP) support...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through October 2025 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through October 2025 

by Truveta Research | Nov 13, 2025 | Research, Research Insights

Respiratory virus–associated hospitalizations declined overall in October 2025 (–31.8%). The rate of RSV-associated hospitalizations in children under five more than doubled for the second consecutive month, signaling early seasonal activity. Rhinovirus remained the...
Hierarchical algorithm to identify pregnancy start and duration using structured EHR data

Hierarchical algorithm to identify pregnancy start and duration using structured EHR data

by Truveta Research | Nov 9, 2025 | Research, Research Insights

Authors: Katherine Brown, PhD, MSN, RN ⊕Truveta, Inc, Bellevue, WA, Amy Sullivan, MS ⊕Truveta, Inc, Bellevue, WA, Esther Kim, PhD ⊕Truveta, Inc, Bellevue, WA, Nadia Tabatabaeepour, MPH ⊕Truveta, Inc, Bellevue, WA, Katherine Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA,...
Population characteristics of a large, linked mother-child EHR dataset from Truveta

Population characteristics of a large, linked mother-child EHR dataset from Truveta

by Truveta Research | Nov 9, 2025 | Research, Research Insights

Authors: Katherine Brown, PhD, MSN, RN ⊕Truveta, Inc, Bellevue, WA, Katherine Kendrick, MPH ⊕Truveta, Inc, Bellevue, WA, Amy Wu ⊕Truveta, Inc, Bellevue, WA, Annika Faucon, PhD ⊕Truveta, Inc, Bellevue, WA, Jordan Swartz, MD ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD...
Leveraging NLP to characterize real-world triptan use and adherence from unstructured EHR data

Leveraging NLP to characterize real-world triptan use and adherence from unstructured EHR data

by Truveta Research | Nov 9, 2025 | Research, Research Insights

Authors: Katherine Brown, PhD, MSN, RN ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Emily Webber, PhD ⊕Truveta, Inc, Bellevue, WA Advanced natural...
Completing the evidence picture with linked EHR and closed claims data

Completing the evidence picture with linked EHR and closed claims data

by Truveta staff | Nov 5, 2025 | Research

Understanding the complete view of healthcare requires seeing both what care is delivered and why. Closed claims data show what care occurs, capturing procedures, pharmacy activity, amount paid, and services delivered beyond a single health system’s network....
« Older Entries
Next Entries »

Share this


Recent posts

  • Real-world evidence on heart failure from GLP-1 and advanced CKD populations
  • Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
  • Use of GLP-1 RAs following label expansion for patients with CVD and overweight or obesity

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.